Fresenius SE & Co KGAA O.N. (FREG)

Real-time derived
Currency in EUR
Disclaimer
29.140
+0.110(+0.38%)
Real-time Data
Day's Range
29.02029.430
52 wk Range
19.69031.220
Prev. Close
29.03
Open
29.06
Day's Range
29.02-29.43
52 wk Range
19.69-31.22
Volume
152,373
Average Volume (3m)
1,102,838
1-Year Change
34.4%
Shares Outstanding
563,237,300
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
38.631
Upside +32.570%

People Also Watch

250.400
RHMG
+0.81%
164.15
CAPP
-0.79%
50.370
1COV
-0.57%
21.91
VNAn
-1.13%
372.85
MUVGn
+0.34%

Fresenius SE & Co KGAA O.N. Company Profile

Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Employees
315233
Market
Germany

Income Statement